While tumor infiltrating CD8+ T cells have been shown to be associated with positive outcomes and FOXP3+ Treg are usually associated with negative outcomes, there is tremendous heterogeneity in the results of IHC-based detection and enumeration of TIL subsets in cancer (10, 12, 30). The gene discussed is CD8A; the disease is neoplasm.